2nd Quarter - Report
THE NICKLES GROUP, LLC for EMERGENT BIOSOLUTIONS
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Appropriations funding for FY 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Health Issues HCR
Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines, issues related to the development, manufacture, and distribution of coronavirus vaccines. S. 3799, PREVENT Pandemics Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.